Financials
Value Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 113 M112 M108 M — Research & development 26 M27 M28 M — Operating income 139 M88 M156 M — Non-Operating Income, Total 36 M17 M7 M — Interest expense, net of interest capitalized 2 M23 M29 M — Non-Operating Income, excl. Interest Expenses -2 M-23 M-29 M — Unusual income/expense 36 M17 M7 M — Pretax income 173 M86 M136 M — Equity in earnings —4 M4 M — Taxes 182 M32 M31 M — Non-controlling/minority interest 26 M13 M20 M — After tax other income/expense ——0 — Net income before discontinued operations -35 M41 M85 M — Discontinued operations ——— — Net income -35 M41 M85 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -35 M41 M85 M — Basic earnings per share (Basic EPS) ——0.53 — Diluted earnings per share (Diluted EPS) —0.260.53 — Average basic shares outstanding —158.7 M158.8 M — Diluted shares outstanding —158.9 M159.3 M — EBITDA 221 M169 M238 M — EBIT 171 M115 M179 M — Cost of revenue 659 M729 M675 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 50 M54 M59 M —